Ads

 

Ads

 

Ads

 

Hubei Biocause Pharmaceutical

Hubei Biocause Pharmaceutical

World Rank (Jan-05-2024)
5,735
Market Cap (Jan-05-2024)
1.971 Billion USD
World Rank (Jul-30-2023)
5,193
Market Cap (Jul-30-2023)
2.336 Billion USD
World Rank (Jan-07-2022)
5,307
Market Cap (Jan-07-2022)
2.640 Billion USD
World Rank (Jan-01-2021)
3,722
Market Cap (Jan-01-2021)
3.690 Billion USD
Headquarters Country
World Region
World Subregion
Annual Revenue in USD
1,775 Million USD
Annual Net Income in USD
68 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
38,404 Million USD
Total Liabilities in USD
32,950 Million USD
Total Equity in USD
5,453 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year

Share

Ads